Ecstasy - Veien til ekstase eller fortvilelse?

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 17, 1997, Pages 2432-2433

  Mørland, Jørg ^a  

^a Statens Rettstoksikologiske Institutt   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; PSYCHEDELIC AGENT;

ADDICTION; ARTICLE; HUMAN;

3,4-METHYLENEDIOXYAMPHETAMINE; HALLUCINOGENS; HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 0031591515     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Webb E, Ashton CH, Kelly P, Kamali F. Alcohol and drug use in UK university students. Lancet 1996; 348: 922-5.
2. St.meld.nr. 16 (1996-97) Narkotikapolitikken 71-81.
3. Creigton FJ, Black DL, Hyde CE. Ecstasy psychosis and flashbacks. Br J Psychiatry 1991; 159: 713-5.
4. Rudnick G, Wall SC. The molecular mechanisms of ecstasy [3,4-methylendioxymetamphetamine (MDMA)]. Serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sei USA 1992; 89: 1817-21.
5. Ames D. Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome - a possible link? JAMA 1993; 269: 869.
6. Friedman R. Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome - a possible link? JAMA 1993; 269: 869-70.
7. Steele TD, McCann UD, Ricaurte GA. 3,4Methylendioxymethamphetamine (MDMA, Ecstasy): pharmacology and toxicology in animals and humans. Addiction 1994; 89: 539-51.
8. Seiden LS, Vosmer G. Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol Biochem Behav 1984; 21: 29-31.
9. Fisher C, Hatzdimitrion G, Wlos J, Katz J, Ricaurte GA. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+) 3,4-metylendioxymethamphetamine (MDMA, Ecstasy). J Neurosci 1995; 15: 5476-85.
10. McCann UD, Ridenour A, Shaham Y, Ricaurte GA. Serotonin neurotoxicity after (+) 3,4-methylenedioxymethamphetamine (MDMA, «Ecstasy»): a controlled study in humans. Neuropsychopharmacology 1994; 10: 129-38.